Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

NVIV | InVivo Therapeutics Holdings Corp

Index	-	P/E	-	EPS (ttm)	-4.43	Insider Own	10.74%	Shs Outstand	3.11M	Perf Week	-0.88%
Market Cap	3.48M	Forward P/E	-	EPS next Y	-547.50	Insider Trans	0.00%	Shs Float	2.77M	Perf Month	-7.44%
Income	-9.38M	PEG	-	EPS next Q	-225.00	Inst Own	3.13%	Short Float / Ratio	0.52% / 0.93	Perf Quarter	-17.04%
Sales	0.00M	P/S	-	EPS this Y	-1244.44%	Inst Trans	57.69%	Short Interest	0.01M	Perf Half Y	9.80%
Book/sh	3.73	P/B	0.30	EPS next Y	39.67%	ROA	-63.83%	Target Price	180.00	Perf Year	-73.89%
Cash/sh	3.45	P/C	0.32	EPS next 5Y	-	ROE	-76.95%	52W Range	0.81 - 7.98	Perf YTD	-52.34%
Dividend	-	P/FCF	-	EPS past 5Y	78.59%	ROI	-79.15%	52W High	-85.96%	Beta	0.84
Dividend %	-	Quick Ratio	9.14	Sales past 5Y	0.00%	Gross Margin	-	52W Low	38.96%	ATR	0.06
Employees	6	Current Ratio	9.14	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	43.34	Volatility	7.59% 4.64%
Optionable	No	Debt/Eq	0.06	EPS Q/Q	68.27%	Profit Margin	-	Rel Volume	2.19	Prev Close	1.16
Shortable	Yes	LT Debt/Eq	0.02	Earnings	-	Payout	-	Avg Volume	15.38K	Price	1.12
Recom	1.00	SMA20	-3.30%	SMA50	-8.76%	SMA200	-25.29%	Volume	9,227	Change	-3.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-17	Downgrade	Raymond James	Outperform → Mkt Perform
May-05-17	Downgrade	Raymond James	Strong Buy → Outperform
Jul-21-16	Initiated	Ladenburg Thalmann	Buy
Jul-07-16	Initiated	Raymond James	Strong Buy	$13

Mar-09-23 12:28PM	Why InVivo Therapeutics Shares Are Plunging Today (Benzinga) -46.48%
08:55AM	InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury (Business Wire)
Oct-11-22 04:01PM	InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules (Business Wire)
Oct-07-22 08:00AM	InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules (Business Wire) -49.25%
Sep-09-22 08:00AM	InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference (Business Wire) +7.44%
08:30AM	Loading…
Jul-13-22 08:30AM	InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel (Business Wire) +8.07%
Jun-08-22 08:30AM	InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery (Business Wire)
Jun-02-22 08:30AM	InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study (Business Wire) -5.75%
Apr-18-22 08:54AM	Why Are InVivo Therapeutics Shares Trading Lower During Premarket Monday? (Benzinga) -22.10%
Apr-14-22 04:49PM	InVivo Therapeutics stock sinks after 1-for-25 reverse stock split announced (MarketWatch) -12.27%
04:30PM	InVivo Therapeutics Announces Reverse Stock Split (Business Wire)
Jan-06-22 08:00AM	InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference (Business Wire)
Sep-09-21 08:00AM	InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference (Business Wire)
Sep-08-21 08:00AM	InVivo Therapeutics Announces 75% Target Enrollment Achieved for the INSPIRE 2.0 Spinal Cord Injury Study (Business Wire)
Jul-19-21 06:13AM	InVivo Therapeutics Holdings (NASDAQ:NVIV) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.) -5.12%
09:13AM	Loading…
Jul-13-21 09:13AM	InVivo Therapeutics Stock Moves Higher On FDA Acceptance Of Preclinical Module For Neuro-Spinal Implant (Benzinga) +12.54%
08:00AM	InVivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Companys Complete HDE Submission (Business Wire)
Jul-06-21 08:05AM	InVivo Therapeutics Urges All Stockholders to Vote at the 2021 Annual Meeting to Be Held on Friday July 16, 2021 (Business Wire) -7.91%
Jun-13-21 11:22PM	Is Invivo Therapeutics (NVIV) A Good Stock To Buy Now? (Insider Monkey)
Mar-12-21 08:00AM	InVivo Therapeutics Announces Presentation at Upcoming M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference (Business Wire) -6.40%
Mar-05-21 08:00AM	InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference (Business Wire) +20.34%
Feb-16-21 08:00AM	InVivo Therapeutics Announces Publication in Peer-Reviewed Journal of Neurosurgery: Spine (Business Wire) +13.38%
Jan-18-21 05:47AM	Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely? (Simply Wall St.)
Oct-26-20 04:15PM	InVivo Therapeutics Announces Closing of $15.0 Million Public Offering (Business Wire)
Oct-22-20 09:15AM	InVivo Therapeutics Announces Pricing of $15.0 Million Public Offering (Business Wire) -47.33%
Sep-11-20 08:30AM	InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference (Business Wire) -5.97%
Apr-17-20 12:19PM	InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (Business Wire) +5.67%
Apr-15-20 07:30PM	InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (Business Wire)
Mar-11-20 04:27PM	InVivo Therapeutics Announces Closing of $7.0 Million Public Offering (Business Wire) -10.61%
Mar-06-20 09:15AM	InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering (Business Wire) -62.24%
04:30PM	Loading…
Feb-03-20 04:30PM	InVivo Therapeutics Announces Reverse Stock Split (Business Wire)
Nov-22-19 04:30PM	InVivo Therapeutics Announces Closing of Public Offering of Common Stock (Business Wire)
08:18AM	The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate (Benzinga)
Nov-21-19 08:00AM	InVivo Therapeutics Announces Pricing of Public Offering of Common Stock (Business Wire) -27.63%
Nov-18-19 08:15AM	InVivo Therapeutics Announces Proposed Public Offering of Common Stock (Business Wire) -37.48%
Nov-12-19 08:00AM	InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors (Business Wire) -6.38%
Oct-29-19 10:51AM	Biotech CEO found guilty of defrauding investors (American City Business Journals) +6.67%
Oct-22-19 08:00AM	InVivo Therapeutics Provides Enrollment Update for INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury (Business Wire) -22.45%
Jul-16-19 08:00AM	InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord (Business Wire)
Jul-12-19 08:00AM	InVivo Therapeutics Announces Postponement of Annual Meeting (Business Wire)
Jun-14-19 08:00AM	InVivo Therapeutics Announces Adjournment of Annual Meeting (Business Wire)
May-29-19 02:54PM	Bob Langer-founded device-maker InVivo starts new trial after patient deaths (American City Business Journals) -5.41%
08:00AM	InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury (Business Wire)
Apr-17-19 08:00AM	InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury (Business Wire)
Apr-01-19 08:15AM	InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update (Business Wire)
Jan-14-19 08:00AM	InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-29-18 08:00AM	InVivo Therapeutics to Present at the LD Micro Main Event on Tuesday December 4th, 2018 (Business Wire)
Nov-19-18 09:00AM	Report: Developing Opportunities within Command Center, Neurotrope, Selecta Biosciences, InVivo Therapeutics, SeaSpine, and Senestech Future Expectations, Projections Moving into 2018 (GlobeNewswire)
Nov-08-18 06:55PM	InVivo: 3Q Earnings Snapshot (Associated Press)
04:30PM	InVivo Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update (Business Wire)
Oct-02-18 08:00AM	InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc. (Business Wire)
Oct-01-18 08:00AM	InVivo Therapeutics Announces Publication of Neuro-Spinal Scaffold Preclinical Data in Peer-Reviewed Journal Biomaterials (Business Wire)
Sep-28-18 08:05AM	InVivo Therapeutics Announces Presentation at the Ladenburg Thalmann 2018 Healthcare Conference and Provides Business Update (Business Wire)
Aug-28-18 08:00AM	InVivo Therapeutics Announces Complete 12-Month Data from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury (Business Wire)
Aug-07-18 07:42PM	InVivo: 2Q Earnings Snapshot (Associated Press)
04:30PM	InVivo Therapeutics Reports 2018 Second Quarter Financial Results (Business Wire)
Jun-25-18 04:05PM	InVivo Therapeutics Announces Closing of $15.2 Million Public Offering, Including the Exercise of Underwriters Overallotment Option (Business Wire)
Jun-21-18 09:00AM	InVivo Therapeutics Announces Pricing of $13.2 Million Underwritten Public Offering (Business Wire) -44.51%
May-24-18 10:35AM	Is InVivo Therapeutics Holdings Corps (NASDAQ:NVIV) Balance Sheet Strong Enough To Weather A Storm? (Simply Wall St.)
May-07-18 06:44PM	InVivo: 1Q Earnings Snapshot (Associated Press) +6.55%
04:30PM	InVivo Therapeutics Reports 2018 First Quarter Financial Results (Business Wire)
Apr-18-18 08:20AM	Todays Research Reports on Stocks to Watch: vTv Therapeutics and InVivo Therapeutics (ACCESSWIRE) -9.26%
Apr-09-18 08:00AM	InVivo Therapeutics Provides Business Update (Business Wire) -30.27%
Mar-19-18 08:00AM	InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the CONTEMPO Registry Study) Findings (Business Wire) -7.47%
Mar-12-18 08:35AM	InVivo reports 4Q loss (Associated Press) -7.61%
08:15AM	InVivo Therapeutics Reports 2017 Year-end Financial Results (Business Wire)
Mar-09-18 10:34AM	Is It Time To Buy InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)? (Simply Wall St.) -7.72%
08:20AM	Todays Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics (ACCESSWIRE)
Mar-08-18 08:00AM	InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury (Business Wire) +49.37%
Feb-05-18 08:00AM	InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer (Business Wire)
Jan-29-18 07:00AM	Blog Exposure - InVivo Therapeutics Signs Share Repurchase Agreement with Lincoln Park Capital (ACCESSWIRE) -13.42%
Jan-26-18 08:00AM	InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital (Business Wire)
Jan-03-18 08:00AM	InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward (Business Wire) -21.43%
Dec-18-17 08:00AM	InVivo Therapeutics Announces Executive Management and Board Changes (Business Wire)
Nov-06-17 08:00AM	InVivo Therapeutics to Present at Canaccord Genuitys Medical Technologies & Diagnostics Forum (Business Wire)
Oct-30-17 06:03PM	InVivo reports 3Q loss (Associated Press)
04:45PM	InVivo Therapeutics Provides Business Update and Reports 2017 Third Quarter Financial Results (Business Wire)
Oct-11-17 10:14AM	What Is InVivo Therapeutics Holdings Corps (NVIV) Share Price Doing? (Simply Wall St.)
Oct-10-17 08:00AM	InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting (Business Wire)
Sep-20-17 08:00AM	InVivo Therapeutics to Present at Ladenburg Thalmann 2017 Healthcare Conference (Business Wire)
Sep-05-17 08:00AM	InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade (Business Wire)
Aug-29-17 05:59PM	InVivo slashes staff and ousts science chief (American City Business Journals)
Aug-28-17 04:30PM	InVivo Therapeutics Announces Strategic Corporate Restructuring (Business Wire)
Aug-10-17 09:00AM	InVivo Therapeutics Announces Exchange of Certain Warrants for Common Stock (Business Wire) -30.00%
Aug-09-17 11:37PM	InVivo reports 2Q loss (Associated Press)
Aug-08-17 06:00PM	InVivo Therapeutics Provides Business Update and Reports 2017 Second Quarter Financial Results (Business Wire) -10.00%
08:00AM	InVivo Therapeutics to Present at Canaccord Genuitys 37th Annual Growth Conference (Business Wire)
Aug-01-17 08:00AM	Today's Research Reports on Stocks to Watch: InVivo Therapeutics Holdings and Dynavax Technologies (ACCESSWIRE) -5.56%
Jul-31-17 12:46PM	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of InVivo Therapeutics Holding Corp. (NVIV) (PR Newswire) -26.53%
11:23AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of InVivo Therapeutics Holding Corp. - NVIV (ACCESSWIRE)
09:45AM	InVivo halts trial of spine injury treatment after third patient dies (American City Business Journals)
08:00AM	InVivo Therapeutics Announces Updates on the INSPIRE Study (Business Wire)
Jul-12-17 08:00AM	InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study (Business Wire)
Jul-11-17 08:00AM	InVivo Therapeutics Opens First Site in the United Kingdom for INSPIRE Study (Business Wire)
Jul-10-17 08:00AM	InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer (Business Wire) -5.32%
Jun-29-17 08:00AM	InVivo Therapeutics Announces UCHealth Memorial Hospital as New Site for INSPIRE Study (Business Wire)
Jun-28-17 09:45AM	Wednesdays Biggest Early Market Movers (24/7 Wall St.)
08:00AM	InVivo Therapeutics Announces Positive Motor Recovery Assessments in Two Patients in the INSPIRE Study of the Neuro-Spinal Scaffold (Business Wire)
Jun-27-17 08:00AM	InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Thomas Jefferson University Hospital (Business Wire) +7.84%
Jun-20-17 08:00AM	InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Allegheny General Hospital (Business Wire) +8.33%

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert S. Langer, Jr. in January 2005 and is headquartered in Cambridge, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVIV | InVivo Therapeutics Holdings Corp

Upgrade your FINVIZ experience